ENTRY       D11073                      Drug
NAME        Tepotinib hydrochloride (USAN);
            Tepotinib hydrochloride hydrate (JAN);
            Tepmetko (TN)
PRODUCT     TEPMETKO (EMD Serono)
FORMULA     C29H28N6O2. HCl. H2O
EXACT_MASS  546.2146
MOL_WEIGHT  547.0478
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EX21
            Chemical structure group: DG03087
            Product (DG03087): D11073<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
  DISEASE   Non-small cell lung cancer (MET exon 14 skipping) [DS:H00014]
TARGET      MET* [HSA_VAR:4233v4] [HSA:4233] [KO:K05099]
  PATHWAY   hsa04014(4233)  Ras signaling pathway
            hsa04151(4233)  PI3K-Akt signaling pathway
            hsa05200(4233)  Pathways in cancer
            hsa05202(4233)  Transcriptional misregulation in cancer
            hsa05223(4233)  Non-small cell lung cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EX Other protein kinase inhibitors
                 L01EX21 Tepotinib
                  D11073  Tepotinib hydrochloride (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Tepotinib
                D11073  Tepotinib hydrochloride (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D11073  Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03087  Tepotinib
                 D11073  Tepotinib hydrochloride
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG03087  Tepotinib
                D11073  Tepotinib hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03087  Tepotinib
                 D11073  Tepotinib hydrochloride
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               MET family
                MET* [HSA_VAR:4233v4]
                 D11073  Tepotinib hydrochloride (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11073
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11073
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11073
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11073
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D11073
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03087  Tepotinib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG03087  Tepotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03087  Tepotinib
DBLINKS     PubChem: 375581020
ATOM        39
            1   N1y N    28.7700  -12.1800
            2   C1x C    28.7700  -13.5800
            3   C1x C    27.5800  -14.2800
            4   C1y C    26.3200  -13.5800
            5   C1x C    26.3200  -12.1800
            6   C1x C    27.5800  -11.4800
            7   C1a C    29.9600  -11.4800
            8   C1b C    25.1300  -14.2800
            9   O2a O    23.9400  -13.5800
            10  C8y C    22.7500  -14.2800
            11  C8x C    22.7500  -15.6800
            12  N5x N    21.4900  -16.3800
            13  C8y C    20.3000  -15.6800
            14  N5x N    20.3000  -14.2800
            15  C8x C    21.4900  -13.5800
            16  C8y C    19.1100  -16.3800
            17  C8x C    19.1100  -17.7800
            18  C8x C    17.8500  -18.4800
            19  C8x C    16.6600  -17.7800
            20  C8y C    16.6600  -16.3800
            21  C8x C    17.8500  -15.6800
            22  C1b C    15.4700  -15.6800
            23  N4y N    14.2800  -16.3800
            24  C8y C    14.2800  -17.7800
            25  C8x C    13.0200  -18.4800
            26  C8x C    11.8300  -17.7800
            27  C8y C    11.8300  -16.3800
            28  N5x N    13.0200  -15.6800
            29  O5x O    15.4700  -18.4800
            30  C8y C    10.6400  -15.6800
            31  C8x C     9.4500  -16.3800
            32  C8y C     8.1900  -15.6800
            33  C8x C     8.1900  -14.2800
            34  C8x C     9.3800  -13.5800
            35  C8x C    10.6400  -14.2800
            36  C3b C     7.0000  -16.3800
            37  N3a N     5.7400  -17.0800
            38  X   Cl   23.7300  -18.9700
            39  O0  O    27.2300  -18.9700
BOND        41
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     1   7 1
            8     4   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14   13  14 1
            15   14  15 2
            16   10  15 1
            17   13  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   16  21 1
            24   20  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 2
            29   26  27 1
            30   27  28 2
            31   23  28 1
            32   24  29 2
            33   27  30 1
            34   30  31 2
            35   31  32 1
            36   32  33 2
            37   33  34 1
            38   34  35 2
            39   30  35 1
            40   32  36 1
            41   36  37 3
///
